BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 30, 2008
View Archived Issues
Preclinical profile of CAL-101 in hematological cancers disclosed
Read More
New BACE1 inhibitors for Alzheimer's disease reported in recent Medivir patent
Read More
Novel DBH inhibitors patented by Bial - Portela
Read More
MT-103 converts MRD-positive ALL into MRD-negative ALL in phase II study
Read More
NDA for crofelemer in HIV-associated diarrhea expected in 2010
Read More
Progen and Avexa sign exclusive and binding merger implementation agreement
Read More
Drais and Diatos sign global license agreement for cancer drug DTS-108
Read More
Avigen sells rights to blood coagulation drug AV-513 to Baxter
Read More
FDA approves Novartis' Gleevec for recurrence following surgical removal of a GIST
Read More
Ligand licenses worldwide rights to LGD-4665 and other ligand thrombopoietin molecules to GSK
Read More
Clinuvel submits IND for confirmatory PK trial of photoprotective afamelanotide
Read More
FDA approves Vasovist intravascular contrast agent
Read More
FDA approves Zolpimist oral spray for insomnia
Read More
Wyeth acquires Thiakis and obesity drug TKS-1225
Read More
FDA grants approval to StemCells to initiate phase I clinical trial of HuCNS-SC in PMD
Read More
European CHMP formally adopts positive opinion for IDM Pharma's Mepact in osteosarcoma
Read More
DMC recommends continuation of phase III trial of Pharmexa's Telovac in pancreatic cancer
Read More
Lundbeck initiates phase II clinical trial of Lu-AA-39959 in bipolar I or II disorder
Read More
FDA approves Ferring's degarelix for advanced prostate cancer
Read More
FDA approves Latisse for hypotrichosis of eyelashes
Read More
Additional indication for Fastic/Starsis approved in Japan
Read More
AEG-35156 plus chemotherapy effective in some patients with refractory acute myeloid leukemia
Read More
Pyronaridine/artesunate demonstrates efficacy against P. falciparum and P. vivax malaria
Read More
Malaria vaccine AMA1-C1/ISA 720 evaluated in phase I study
Read More
Novel MGL/FAAH inhibitors emerge from sanofi-aventis R&D
Read More